Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Identification of novel HIV-1-derived HLA-E-binding peptides

Hannoun Z. et al, (2018), Immunology Letters, 202, 65 - 72

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1

Borthwick NJ. et al, (2018), PLOS ONE, 13, e0197299 - e0197299

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers

Capucci S. et al, (2017), PLOS ONE, 12, e0181886 - e0181886

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens

Moyo N. et al, (2017), PLOS ONE, 12, e0181382 - e0181382

Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines

Borthwick N. et al, (2017), PLOS ONE, 12, e0176418 - e0176418

A statistical approach to determining responses to individual peptides from pooled-peptide ELISpot data

Ström P. et al, (2016), Journal of Immunological Methods, 435, 43 - 49

Control of HIV-1 replication in vitro by vaccine-induced human CD8+ T cells through conserved subdominant Pol epitopes

Ahmed T. et al, (2016), Vaccine, 34, 1215 - 1224

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults

Mutua G. et al, (2016), Molecular Therapy - Methods & Clinical Development, 3, 16061 - 16061

Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells

Ternette N. et al, (2015), Journal of Virology, 89, 5760 - 5771

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques

Borthwick NJ. et al, (2015), Immunity, Inflammation and Disease, 3, 82 - 93

PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi

Njuguna IN. et al, (2014), Vaccine, 32, 5801 - 5808

PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi

Njuguna IN. et al, (2014), Vaccine, 32, 5801 - 5808

Phase I Clinical Trial HIV-CORE002 of a Universal T-cell Vaccine: Mapping of CD8+ T Cell Epitopes

Borthwick NJ. et al, (2014), AIDS Research and Human Retroviruses, 30, A187 - A187

Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

Borthwick N. et al, (2014), Molecular Therapy, 22, 464 - 475

A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants

Afolabi MO. et al, (2013), PLoS ONE, 8, e78289 - e78289

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial

Borthwick NJ. et al, (2012), Retrovirology, 9

Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques

Rosario M. et al, (2012), AIDS, 26, 275 - 284

The biology of micrometastases from uveal melanoma

Borthwick NJ. et al, (2011), Journal of Clinical Pathology, 64, 666 - 671

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Rosario M. et al, (2010), Journal of Virology, 84, 7815 - 7821

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques

Rosario M. et al, (2010), European Journal of Immunology, 40, 1973 - 1984

Load More

Include forthcoming?